Cargando…
The impact of glucocorticoids and anti-cd20 therapy on cervical human papillomavirus infection risk in women with systemic lupus erythematosus
OBJECTIVE: To identify the prevalence and factors associated with cervical human papillomavirus infection in women with systemic lupus erythematosus METHODS: This cross-sectional study collected traditional and systemic lupus erythematosus-related disease risk factors, including conventional and bio...
Autores principales: | Mendoza-Pinto, Claudia, Garcia-Carrasco, Mario, Vallejo-Ruiz, Veronica, Taboada-Cole, Alejandro, Muñoz-Guarneros, Margarita, Solis-Poblano, Juan Carlos, Pezzat-Said, Elias, Aguilar-Lemarroy, Adriana, Jave-Suarez, Luis Felipe, de Lara, Luis Vazquez, Ramos-Alvarez, Gloria, Reyes-Leyva, Julio, Lopez-Colombo, Aurelio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3840372/ https://www.ncbi.nlm.nih.gov/pubmed/24473503 http://dx.doi.org/10.6061/clinics/2013(12)01 |
Ejemplares similares
-
Glucocorticoid‐induced osteonecrosis in systemic lupus erythematosus patients
por: Kaneko, Kaichi, et al.
Publicado: (2021) -
Glucocorticoids in Systemic Lupus Erythematosus. Ten Questions and Some Issues
por: Porta, Sabrina, et al.
Publicado: (2020) -
The Role of Circulating Regulatory T Cell Levels on Subclinical Atherosclerosis and Cardiovascular Risk Factors in Women with Systemic Lupus Erythematosus
por: García-Carrasco, Mario, et al.
Publicado: (2018) -
The effects of glucocorticoid treatment on cardiovascular system in patients with systemic lupus erythematosus
por: Blachut, Dominika, et al.
Publicado: (2022) -
Glucocorticoid Withdrawal Symptoms and Quality of Life in Patients with Systemic Lupus Erythematosus
por: Karoonkatima, Matee, et al.
Publicado: (2023)